share_log

NexImmune | S-8 POS: S-8 POS

SEC ·  Aug 28 04:13
Summary by Futu AI
NexImmune, Inc., a biopharmaceutical company, has filed Post-Effective Amendment No. 1 with the U.S. Securities and Exchange Commission (SEC) on August 27, 2024, to deregister all shares of common stock previously registered under three separate Registration Statements on Form S-8. These statements were associated with the company's employee benefit and equity plans from 2017, 2018, and 2021. The deregistration affects a total of 290,210 shares, adjusted for a 1-for-25 reverse stock split that took place on October 18, 2023. This move follows the stockholders' approval of the company's dissolution, liquidation, and winding-up, as disclosed in a Form 8-K filed on August 15, 2024. The company has terminated all offerings of its securities and has removed and withdrawn from registration all unsold securities as of the date of the amendment. The President of NexImmune, Craig Jalbert, signed the amendment, indicating the company's compliance with the requirements for filing and the termination of the effectiveness of the Registration Statements.
NexImmune, Inc., a biopharmaceutical company, has filed Post-Effective Amendment No. 1 with the U.S. Securities and Exchange Commission (SEC) on August 27, 2024, to deregister all shares of common stock previously registered under three separate Registration Statements on Form S-8. These statements were associated with the company's employee benefit and equity plans from 2017, 2018, and 2021. The deregistration affects a total of 290,210 shares, adjusted for a 1-for-25 reverse stock split that took place on October 18, 2023. This move follows the stockholders' approval of the company's dissolution, liquidation, and winding-up, as disclosed in a Form 8-K filed on August 15, 2024. The company has terminated all offerings of its securities and has removed and withdrawn from registration all unsold securities as of the date of the amendment. The President of NexImmune, Craig Jalbert, signed the amendment, indicating the company's compliance with the requirements for filing and the termination of the effectiveness of the Registration Statements.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.